About this Journal Submit a Manuscript Table of Contents
Parkinson’s Disease
Volume 2012 (2012), Article ID 829207, 12 pages
http://dx.doi.org/10.1155/2012/829207
Review Article

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?

1Diabetes and Obesity Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
2School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia

Received 20 January 2012; Accepted 14 March 2012

Academic Editor: Catarina Resende de Oliveira

Copyright © 2012 David Protter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Thomas and M. F. Beal, “Parkinson's disease.,” Human Molecular Genetics, vol. 16, pp. R183–R194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. V. Schapira, “Mitochondrial dysfunction in Parkinson's disease,” Cell Death and Differentiation, vol. 14, no. 7, pp. 1261–1266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Mizuno, S. Ohta, M. Tanaka et al., “Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease,” Biochemical and Biophysical Research Communications, vol. 163, pp. 1450–1455, 1989.
  4. A. H. V. Schapira, J. M. Cooper, D. Dexter, P. Jenner, J. B. Clark, and C. D. Marsden, “Mitochondrial Complex I deficiency in Parkinson's disease,” The Lancet, vol. 1, no. 8649, p. 1269, 1989. View at Scopus
  5. A. H. V. Schapira, J. M. Cooper, D. Dexter, J. B. Clark, P. Jenner, and C. D. Marsden, “Mitochondrial Complex I deficiency in Parkinson's disease,” Journal of Neurochemistry, vol. 54, no. 3, pp. 823–827, 1990. View at Scopus
  6. P. M. Keeney, J. Xie, R. A. Capaldi, and J. P. Bennett, “Parkinson's disease brain mitochondrial Complex I has oxidatively damaged subunits and is functionally impaired and misassembled,” Journal of Neuroscience, vol. 26, no. 19, pp. 5256–5264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Yoshino, Y. Nakagawa-Hattori, T. Kondo, et al., “Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease,” Journal of Neural Transmission, vol. 4, no. 1, pp. 27–34, 1992. View at Publisher · View at Google Scholar
  8. W. D. Parker Jr., S. J. Boyson, and J. K. Parks, “Abnormalities of the electron transport chain in idiopathic Parkinson's disease,” Annals of Neurology, vol. 26, no. 6, pp. 719–723, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Shoffner, R. L. Watts, J. L. Juncos, A. Torroni, and D. C. Wallace, “Mitochondrial oxidative phosphorylation defects in Parkinson's disease,” Annals of Neurology, vol. 30, no. 3, pp. 332–339, 1991. View at Scopus
  10. A. R. Esteves, J. Lu, M. Rodova et al., “Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer,” Journal of Neurochemistry, vol. 113, no. 3, pp. 674–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. H. Swerdlow, J. K. Parks, S. W. Miller et al., “Origin and functional consequences of the Complex I defect in Parkinson's disease,” Annals of Neurology, vol. 40, no. 4, pp. 663–671, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Zheng, Z. Liao, J. J. Locascio, et al., “PGC-1{alpha}, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease,” Sci Transl Med, vol. 2, no. 52, p. 52ra73, 2010. View at Publisher · View at Google Scholar
  13. T. M. Dawson and V. L. Dawson, “Rare genetic mutations shed light on the pathogenesis of Parkinson disease,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 145–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. B. Sherer, R. Betarbet, C. M. Testa et al., “Mechanism of toxicity in rotenone models of Parkinson's disease,” Journal of Neuroscience, vol. 23, no. 34, pp. 10756–10764, 2003. View at Scopus
  15. M. F. Beal, “Experimental models of Parkinson's disease,” Nature Reviews Neuroscience, vol. 2, no. 5, pp. 325–334, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” Journal of Physiology, vol. 552, no. 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Hayashi, C. Ishimori, K. Takahashi-Niki et al., “DJ-1 binds to mitochondrial Complex I and maintains its activity,” Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 667–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Mullett and D. A. Hinkle, “DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity,” Journal of Neurochemistry, vol. 117, no. 3, pp. 375–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. J. Braun and B. Westermann, “Mitochondrial dynamics in yeast cell death and aging,” Biochemical Society Transactions, vol. 39, pp. 1520–1526, 2011.
  20. A. Kowald and T. B. Kirkwood, “The evolution and role of mitochondrial fusion and fission in aging and disease,” Communicative & Integrative Biology, vol. 4, pp. 627–629, 2011.
  21. X. Wang, D. Winter, G. Ashrafi et al., “PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility,” Cell, vol. 147, pp. 893–906, 2011.
  22. E. K. Tan and L. M. Skipper, “Pathogenic mutations in Parkinson disease,” Human Mutation, vol. 28, no. 7, pp. 641–653, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Polymeropoulos, C. Lavedan, E. Leroy et al., “Mutation in the α-Synuclein gene identified in families with Parkinson's disease,” Science, vol. 276, no. 5321, pp. 2045–2047, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. T. L. Edwards, W. K. Scott, C. Almonte et al., “Genome-Wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for parkinson disease,” Annals of Human Genetics, vol. 74, no. 2, pp. 97–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. I. F. Mata, M. Shi, P. Agarwal et al., “SNCA variant associated with Parkinson disease and plasma α-Synuclein level,” Archives of Neurology, vol. 67, no. 11, pp. 1350–1356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. I. F. Mata, D. Yearout, V. Alvarez et al., “Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease,” Movement Disorders, vol. 26, no. 5, pp. 819–823, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Simón-Sánchez, C. Schulte, J. M. Bras et al., “Genome-wide association study reveals genetic risk underlying Parkinson's disease,” Nature Genetics, vol. 41, no. 12, pp. 1308–1312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Spencer, V. Plagnol, A. Strange et al., “Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21,” Human Molecular Genetics, vol. 20, no. 2, Article ID ddq469, pp. 345–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Bartels, L. S. Ahlstrom, A. Leftin et al., “The N-terminus of the intrinsically disordered protein α-Synuclein triggers membrane binding and helix folding,” Biophysical Journal, vol. 99, no. 7, pp. 2116–2124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Abeliovich, Y. Schmitz, I. Fariñas et al., “Mice lacking α-Synuclein display functional deficits in the nigrostriatal dopamine system,” Neuron, vol. 25, no. 1, pp. 239–252, 2000. View at Scopus
  31. M. S. Goldberg and P. T. Lansbury, “Is there a cause-and-effect relationship between α-Synuclein fibrillization and Parkinson's disease?” Nature Cell Biology, vol. 2, no. 7, pp. E115–E119, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. B. D. van Rooijen, M. M. A. E. Claessens, and V. Subramaniam, “Membrane interactions of oligomeric alpha-Synuclein: potential role in Parkinson's disease,” Current Protein and Peptide Science, vol. 11, no. 5, pp. 334–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Cooper, A. D. Gitler, A. Cashikar et al., “α-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models,” Science, vol. 313, no. 5785, pp. 324–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Martinez-Vicente, Z. Talloczy, S. Kaushik et al., “Dopamine-modified α-Synuclein blocks chaperone-mediated autophagy,” Journal of Clinical Investigation, vol. 118, no. 2, pp. 777–778, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. K. S. P. McNaught, R. Belizaire, O. Isacson, P. Jenner, and C. W. Olanow, “Altered proteasomal function in sporadic Parkinson's disease,” Experimental Neurology, vol. 179, no. 1, pp. 38–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. L. J. Hsu, Y. Sagara, A. Arroyo et al., “α-Synuclein promotes mitochondrial deficit and oxidative stress,” The American Journal of Pathology, vol. 157, no. 2, pp. 401–410, 2000. View at Scopus
  37. D. D. Song, C. W. Shults, A. Sisk, E. Rockenstein, and E. Masliah, “Enhanced substantia nigra mitochondrial pathology in human α-Synuclein transgenic mice after treatment with MPTP,” Experimental Neurology, vol. 186, no. 2, pp. 158–172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. L. J. Su, P. K. Auluck, T. F. Outeiro et al., “Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models,” DMM Disease Models and Mechanisms, vol. 3, no. 3-4, pp. 194–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Shavali, H. M. Brown-Borg, M. Ebadi, and J. Porter, “Mitochondrial localization of alpha-Synuclein protein in alpha-Synuclein overexpressing cells,” Neuroscience Letters, vol. 439, no. 2, pp. 125–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. W. W. Li, R. Yang, J. C. Guo et al., “Localization of α-Synuclein to mitochondria within midbrain of mice,” NeuroReport, vol. 18, no. 15, pp. 1543–1546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. I. M. Pranke, V. Morello, J. Bigay et al., “α-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding,” Journal of Cell Biology, vol. 194, no. 1, pp. 89–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. N. B. Cole, D. DiEuliis, P. Leo, D. C. Mitchell, and R. L. Nussbaum, “Mitochondrial translocation of α-Synuclein is promoted by intracellular acidification,” Experimental Cell Research, vol. 314, no. 10, pp. 2076–2089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada, “Mitochondrial import and accumulation of α-Synuclein impair Complex I in human dopaminergic neuronal cultures and Parkinson disease brain,” Journal of Biological Chemistry, vol. 283, no. 14, pp. 9089–9100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Devi and H. K. Anandatheerthavarada, “Mitochondrial trafficking of APP and alpha-Synuclein: relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 11–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Kamp, N. Exner, A. K. Lutz et al., “Inhibition of mitochondrial fusion by α-Synuclein is rescued by PINK1, Parkin and DJ-1,” The EMBO Journal, vol. 29, no. 20, pp. 3571–3589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Liu, C. Zhang, J. Yin et al., “α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates Complex I activity,” Neuroscience Letters, vol. 454, no. 3, pp. 187–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Nakamura, V. M. Nemani, F. Azarbal et al., “Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein α-synuclein,” Journal of Biological Chemistry, vol. 286, no. 23, pp. 20710–20726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. W. D. Parker, J. K. Parks, and R. H. Swerdlow, “Complex I deficiency in Parkinson's disease frontal cortex,” Brain Research, vol. 1189, no. 1, pp. 215–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Loeb, E. Yakunin, A. Saada, and R. Sharon, “The transgenic overexpression of α-Synuclein and not its related pathology associates with Complex I inhibition,” Journal of Biological Chemistry, vol. 285, no. 10, pp. 7334–7343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S. J. Chinta, J. K. Mallajosyula, A. Rane, and J. K. Andersen, “Mitochondrial alpha-Synuclein accumulation impairs Complex I function in dopaminergic neurons and results in increased mitophagy in vivo,” Neuroscience Letters, vol. 486, no. 3, pp. 235–239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. J. Perrin, W. S. Woods, D. F. Clayton, and J. M. George, “Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 41958–41962, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Banerjee, M. Sinha, C. L. L. Pham et al., “α-Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease,” FEBS Letters, vol. 584, no. 8, pp. 1571–1576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. S. Parihar, A. Parihar, M. Fujita, M. Hashimoto, and P. Ghafourifar, “Alpha-Synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 10, pp. 2015–2024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Osman, D. R. Voelker, and T. Langer, “Making heads or tails of phospholipids in mitochondria,” Journal of Cell Biology, vol. 192, no. 1, pp. 7–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Sakamoto, T. Inoue, Y. Otomo et al., “Deficiency of cardiolipin synthase causes abnormal mitochondrial function and morphology in germ cells of Caenorhabditis elegans,” The Journal of Biological Chemistry, vol. 287, no. 7, pp. 4590–4601, 2012.
  56. F. Jiang, M. T. Ryan, M. Schlame et al., “Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22387–22394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Fry and D. E. Green, “Cardiolipin requirement for electron transfer in Complex I and III of the mitochondrial respiratory chain.,” Journal of Biological Chemistry, vol. 256, no. 4, pp. 1874–1880, 1981. View at Scopus
  58. C. E. Ellis, E. J. Murphy, D. C. Mitchell et al., “Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking α-Synuclein,” Molecular and Cellular Biology, vol. 25, no. 22, pp. 10190–10201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Büeler, “Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease,” Experimental Neurology, vol. 218, no. 2, pp. 235–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. A. R. Winslow, C. W. Chen, S. Corrochano et al., “α-Synuclein impairs macroautophagy: implications for Parkinson's disease,” Journal of Cell Biology, vol. 190, no. 6, pp. 1023–1037, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. V. Choubey, D. Safiulina, A. Vaarmann et al., “Mutant A53T α-Synuclein induces neuronal death by increasing mitochondrial autophagy,” Journal of Biological Chemistry, vol. 286, no. 12, pp. 10814–10824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. C. M. Fader and M. I. Colombo, “Autophagy and multivesicular bodies: two closely related partners,” Cell Death and Differentiation, vol. 16, no. 1, pp. 70–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Gruenberg, “The endocytic pathway: a mosaic of domains,” Nature Reviews Molecular Cell Biology, vol. 2, no. 10, pp. 721–730, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Görlach, P. Klappa, and T. Kietzmann, “The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control,” Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1391–1418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. B. Kornmann, E. Currie, S. R. Collins et al., “An ER-mitochondria tethering complex revealed by a synthetic biology screen,” Science, vol. 325, no. 5939, pp. 477–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. M. Shaw and D. R. Winge, “Shaping the mitochondrion: mitochondrial biogenesis, dynamics and dysfunction. Conference on mitochondrial assembly and dynamics in health and disease,” EMBO Reports, vol. 10, no. 12, pp. 1301–1305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. D. M. Arduíno, A. R. Esteves, S. M. Cardoso, and C. R. Oliveira, “Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease,” Neurochemistry International, vol. 55, no. 5, pp. 341–348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J. R. Friedman, L. L. Lackner, M. West, J. R. DiBenedetto, J. Nunnari, and G.K. Voeltz, “ER tubules mark sites of mitochondrial division,” Science, vol. 334, pp. 358–362, 2011.
  69. J. J. M. Hoozemans, E. S. van Haastert, P. Eikelenboom, R. A. I. de Vos, J. M. Rozemuller, and W. Scheper, “Activation of the unfolded protein response in Parkinson's disease,” Biochemical and Biophysical Research Communications, vol. 354, no. 3, pp. 707–711, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. N. Thayanidhi, J. R. Helm, D. C. Nycz, M. Bentley, Y. Liang, and J. C. Hay, “α-Synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs,” Molecular Biology of the Cell, vol. 21, no. 11, pp. 1850–1863, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Rath and D. Haller, “Mitochondria at the interface between danger signaling and metabolism: role of unfolded protein responses in chronic inflammation,” Inflammatory Bowel Diseases. In press. View at Publisher · View at Google Scholar
  72. P. C. Chiang, C. L. Chien, S. L. Pan et al., “Induction of endoplasmic reticulum stress and apoptosis by a marine prostanoid in human hepatocellular carcinoma,” Journal of Hepatology, vol. 43, no. 4, pp. 679–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. O. M. De Brito and L. Scorrano, “An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship,” The EMBO Journal, vol. 29, no. 16, pp. 2715–2723, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Koshkin and M. L. Greenberg, “Oxidative phosphorylation in cardiolipin-lacking yeast mitochondria,” Biochemical Journal, vol. 347, no. 3, pp. 687–691, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. H. Sheng and Q. Cai, “Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration,” Nature Reviews Neuroscience, vol. 13, pp. 77–93, 2012.
  76. R. M. Zhou, Y. X. Huang, X. L. Li, et al., “Molecular interaction of α-Synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells,” Molecular Biology Reports, vol. 37, no. 7, pp. 3183–3192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Chen, J. Jin, J. Davis et al., “Oligomeric alpha-Synuclein inhibits tubulin polymerization,” Biochemical and Biophysical Research Communications, vol. 356, pp. 548–553, 2007.
  78. M. A. Alim, Q. L. Ma, K. Takeda et al., “Demonstration of a role for α-Synuclein as a functional microtubule-associated protein,” Journal of Alzheimer's Disease, vol. 6, no. 4, pp. 435–442, 2004, discussion 443–449. View at Scopus
  79. D. Lindholm, H. Wootz, and L. Korhonen, “ER stress and neurodegenerative diseases,” Cell Death and Differentiation, vol. 13, no. 3, pp. 385–392, 2006. View at Publisher · View at Google Scholar
  80. M. Kim, W. Jung, I. H. Lee, G. Bhak, S.R. Paik, and J. S. Hahn, “Impairment of microtubule system increases alpha-Synuclein aggregation and toxicity,” Biochemical and Biophysical Research Communications, vol. 365, pp. 628–635, 2008.
  81. R. E. J. Musgrove, A. E. King, and T. C. Dickson, “Neuroprotective upregulation of endogenous alpha-Synuclein precedes ubiquitination in cultured dopaminergic neurons,” Neurotoxicity Research, vol. 19, no. 4, pp. 592–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. E. J. Ryu, H. P. Harding, J. M. Angelastro, O. V. Vitolo, D. Ron, and L. A. Greene, “Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease,” Journal of Neuroscience, vol. 22, no. 24, pp. 10690–10698, 2002. View at Scopus
  83. J. H. Lim, H. J. Lee, M. Ho Jung, and J. Song, “Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance,” Cellular Signalling, vol. 21, no. 1, pp. 169–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. J. W. Lee, W. H. Kim, J. Yeo, and M. H. Jung, “ER stress is implicated in mitochondrial dysfunction-induced apoptosis of pancreatic beta cells.,” Molecules and cells, vol. 30, no. 6, pp. 545–549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Nath, J. Goodwin, Y. Engelborghs, and D. L. Pountney, “Raised calcium promotes α-Synuclein aggregate formation,” Molecular and Cellular Neuroscience, vol. 46, no. 2, pp. 516–526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Lee, M. T. Park, B.H. Choi et al., “Endoplasmic reticulum stress-induced JNK activation is a critical event leading to mitochondria-mediated cell death caused by beta-lapachone treatment,” PLoS One, vol. 6, Article ID e21533, 2011.
  87. E. Clementi, G. C. Brown, M. Feelisch, and S. Moncada, “Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial Complex I and protective action of glutathione,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7631–7636, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Nakamura and S. A. Lipton, “S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases,” Antioxidants and Redox Signaling, vol. 14, no. 8, pp. 1479–1492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. Z. Yu, X. Xu, Z. Xiang et al., “Nitrated α-Synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats,” PLoS ONE, vol. 5, no. 4, Article ID e9956, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. B. I. Giasson, J. E. Duda, I. V. J. Murray et al., “Oxidative damage linked to neurodegeneration by selective α-Synuclein nitration in synucleinopathy lesions,” Science, vol. 290, no. 5493, pp. 985–989, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Levecque, A. Elbaz, J. Clavel et al., “Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study,” Human Molecular Genetics, vol. 12, no. 1, pp. 79–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Sarkar, V. I. Korolchuk, M. Renna et al., “Complex inhibitory effects of nitric oxide on autophagy,” Molecular Cell, vol. 43, no. 1, pp. 19–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. E. Sevcsik, A. J. Trexler, J. M. Dunn, and E. Rhoades, “Allostery in a disordered protein: oxidative modifications to α-Synuclein act distally to regulate membrane binding,” Journal of the American Chemical Society, vol. 133, no. 18, pp. 7152–7158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. V. N. Uversky, G. Yamin, L. A. Munishkina et al., “Effects of nitration on the structure and aggregation of α-Synuclein,” Molecular Brain Research, vol. 134, no. 1, pp. 84–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. E. H. Norris, B. I. Giasson, H. Ischiropoulos, and V. M. Y. Lee, “Effects of oxidative and nitrative challenges on α-Synuclein fibrillogenesis involve distinct mechanisms of protein modifications,” Journal of Biological Chemistry, vol. 278, no. 29, pp. 27230–27240, 2003. View at Publisher · View at Google Scholar · View at Scopus